echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The latest procurement progress and clinical use proportions of 157 nationally sourced varieties are at a glance!

    The latest procurement progress and clinical use proportions of 157 nationally sourced varieties are at a glance!

    • Last Update: 2021-12-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This week, the latest implementation data of the four batches of national procurement in Jiangxi Province and the first batch of provincial procurement results are available again.
    The data is as of September 30, 2021.
    The data are shared as follows
    .

    ##

    ##

    The results of the first batch of national procurement of Jiangxi selected drugs from December 20, 2020 have entered the second procurement cycle.
    From December 20, 2020 to September 30, 2021, the procurement situation is as follows:

    Purchase quantity and amount

    The total number of selected drugs purchased in the 12 alliance regions of the province is 470,964,800 pieces/piece/bag
    .


    The province’s total purchase amount is 447.


    Completion progress and proportion of selected medicines

    The province's total procurement of selected drugs accounted for 177.
    96% of the total agreed purchases, and the proportion of the total purchases of all drugs of the same product regulations was 93.
    66%
    .

    Online delivery rate

    The province's overall online distribution rate is 87.
    98%
    .

    ##

    ##

    The results of the second batch of national procurement of Jiangxi selected drugs from April 11, 2021 will enter the second procurement cycle.
    From April 11, 2021 to September 30, 2021, the procurement situation is as follows:

    Purchase quantity and amount

    The total number of selected drugs purchased in the 12 alliance regions of the province is 194,681,100 pieces/piece/bag
    .


    The province's total purchase amount is 94.


    Completion progress and proportion of selected medicines

    The province’s total purchases of selected drugs accounted for 99.
    21% of the total agreed purchases, and accounted for 89.
    56% of the total purchases of all drugs under the same product regulations
    .

    Online delivery rate

    The overall online distribution rate of the province is 73.
    10%
    .

    ##

    ##

    The third batch of national procurement of Jiangxi selected drugs in Jiangxi will be implemented from November 19, 2020.
    As of September 30, 2021, the procurement situation is as follows:

    Purchase quantity and amount

    The total number of selected drugs purchased in the 12 alliance regions of the province is 396,982,200 pieces/piece/bag
    .


    The province's total purchase amount is 190,454,100 yuan, accounting for 59.


    Completion progress and proportion of selected medicines

    The province’s total purchases of selected drugs accounted for 158.
    23% of the total agreed purchases and 66.
    98% of the total purchases of all drugs under the same product regulations
    .

    Online delivery rate

    The province's overall online distribution rate is 65.
    79%
    .

    ##

    ##

    The fourth batch of national procurement of Jiangxi selected drugs in Jiangxi will be implemented from April 30, 2021.
    As of September 30, 2021, the procurement situation is as follows:

    Purchase quantity and amount

    The total number of selected drugs purchased in the 12 alliance regions of the province is 98,722,500 tablets/piece/bag
    .


    The province's total purchase amount is 111,155,100 yuan, accounting for 79.


    Completion progress and proportion of selected medicines

    The province’s total purchases of selected drugs accounted for 112.
    97% of the total agreed purchases, and 92.
    89% of the total purchases of all drugs under the same product regulations
    .

    Online delivery rate

    The province's overall online distribution rate was 86.
    20%
    .

    ##

    ##

    The results of the first batch of Jiangxi selected drugs for mass procurement in Jiangxi will be implemented from December 24, 2020.
    As of September 30, 2021, the procurement status is as follows:

    Purchase quantity and amount

    The total number of selected drugs purchased in the 12 alliance regions of the province is 31,545,800 pieces/piece/bag
    .


    The province's total purchase amount is 139,562,900 yuan, accounting for 86.


    Completion progress and proportion of selected medicines

    The province’s total purchases of selected drugs accounted for 151.


    Online delivery rate

    The overall online distribution rate of the province is 87.


    #Selected varieties and payment situation#

    #Selected varieties and payment situation#

    As of the end of September 2021, the total bills (including the first-year procurement cycle) of the five batches of selected drugs in the province's 12 procurement alliances were 1.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.